TherapeuticsMD Inc banner

TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 2.08 USD -0.48% Market Closed
Market Cap: $24.1m

TherapeuticsMD Inc
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

TherapeuticsMD Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
TherapeuticsMD Inc
NASDAQ:TXMD
Intangible Assets
$3.9m
CAGR 3-Years
-53%
CAGR 5-Years
-38%
CAGR 10-Years
12%
Johnson & Johnson
NYSE:JNJ
Intangible Assets
$50.4B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Intangible Assets
$19.1B
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
30%
Pfizer Inc
NYSE:PFE
Intangible Assets
$53.7B
CAGR 3-Years
7%
CAGR 5-Years
14%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Intangible Assets
$26.7B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Intangible Assets
$6.5B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
3%
No Stocks Found

TherapeuticsMD Inc
Glance View

Market Cap
24.1m USD
Industry
Pharmaceuticals

TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 416 full-time employees. The company went IPO on 2001-01-31. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

TXMD Intrinsic Value
Not Available

See Also

What is TherapeuticsMD Inc's Intangible Assets?
Intangible Assets
3.9m USD

Based on the financial report for Sep 30, 2025, TherapeuticsMD Inc's Intangible Assets amounts to 3.9m USD.

What is TherapeuticsMD Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
12%

Over the last year, the Intangible Assets growth was -12%. The average annual Intangible Assets growth rates for TherapeuticsMD Inc have been -53% over the past three years , -38% over the past five years , and 12% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett